tiprankstipranks
pc:carto

Cartography Biosciences Inc

Cartography Biosciences Inc. is an oncology company focused on developing antibody-based therapies that precisely target tumors. Utilizing its ATLAS and SUMMIT drug discovery platforms, Cartography leverages extensive datasets and advanced machine learning to identify novel tumor antigens. Its lead program, CBI-1214, is a T-cell engager targeting colorectal cancer, designed to optimize anti-tumor activity with minimal impact on healthy cells. The company is positioning itself as a leader in the development of next-generation T-cell engaging therapeutics.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$67M
Total Amount Raised$67M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$67M
Latest Funding Amount$67M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 08, 2025
Series B
$67.00M

Investors

Investor Name
Funding Round

Related News and Analysis